Oral Presentation

[27V07-pm] ワクチン・生理活性物質

Sat. Mar 27, 2021 3:03 PM - 5:03 PM [Room V07] Oral Presentation 7 (Online)

座長：花輪智子（杏林大医）、伊從光洋（金沢大院医薬保）

+Add all to schedule

3:03 PM - 3:15 PM

[27V07-pm09] Application of M cell target molecule TGDK to influenza mucosal vaccine development

○Naoki Kishimoto¹, Nagisa Nakata², Toshimasa Takasaki¹, Tsubasa Tani², Ryotarou Mitsumata², Shogo Misumi¹ (1. Grad. Sch. Pharm. Sci., Kumamoto Univ., 2. Denka Co.,Ltd.)

3:15 PM - 3:27 PM

[27V07-pm10] The relevance of inactivation treatment for Flu vaccine and immunoresponse.

○Ryotarou Mitsumata¹, Manabu Kumakura¹, Tsubasa Tani¹ (1. R&D Division, Gosen site, Denka Co., Ltd.)

3:27 PM - 3:39 PM

[27V07-pm11] Age-related changes in immunogenicity of influenza vaccine.

○Tomohiro Narahara¹, Nagisa Nakata¹, Naoki Kishimoto², Ryotarou Mitsumata¹, Shogo Misumi² (1. R&D Division, Gosen site, Denka Co., Ltd., 2. Grad. Sch. Pharm. Sci., Kumamoto Univ.)

3:39 PM - 3:51 PM

[27V07-pm12] Comparison of Immunogenicity between Inactivated Influenza Whole virion and Split virion in Subcutaneous or Intradermal administration.

○Nagisa Nakata¹, Asumi Kanda¹, Ryotarou Mitsumata¹ (1. R&D Division, Gosen site, Denka Co., Ltd)

Withdrawn

3:51 PM - 4:03 PM

[27V07-pm13S] [Withdrawn]

4:03 PM - 4:15 PM

[27V07-pm14] Effect of extracellular vesicles contained in vaccine on vaccine safety and efficacy.

○Takuma Gotanda¹, Naoki Kishimoto², Toshimasa Takasaki², Nobutoki Takamune³, Ryotarou Mitsumata¹, Shogo Misumi² (1. R&D Division, Gosen site, Denka Co., Ltd., 2. Grad. Sch. Pharm. Sci., Kumamoto Univ., 3. KIDO, Kumamoto Univ.)

4:15 PM - 4:27 PM

[27V07-pm15] The isolation and analysis of a novel temperature sensitive SARS-CoV-2 strain for the development of live attenuated vaccine

○Shinya Okamura^1,2, Akiho Kashiwabara^1,2, Hidehiko Suzuki^1,2, Hirotaka Ebina^1,2,3 (1. The research foundation for microbial diseases of Osaka University,, 2. Institute for Open and Transdisciplinary Research Initiatives, 3. Research Institute for Microbial Diseases)

4:27 PM - 4:39 PM

[27V07-pm16S] Investigation for factors related with the immune induction mechanism unique to transcutaneous vaccine formulations applying microneedle array

○Arisa Sugiyama¹, Masashi tachibana¹, naoki okada¹ (1. Grad. Sch. Pharm. Sci., Osaka Univ.)

4:39 PM - 4:51 PM

[27V07-pm17] Lactobacillus paracasei IJH-SONE68-derived exopolysaccharide prevents and improves the dextran sulfate sodium-induced ulcerative colitis in mice

○Masafumi Noda¹, Narandalai Danshiitsoodol¹, Keishi Kanno², Tomoyuki Uchida³, Masanori Sugiyama¹ (1. Grad. Sch. Biomed. Health Sci., Hiroshima Univ., 2. Hiroshima Univ. Hospital, 3. Sone Farm, Co., Ltd.)

4:51 PM - 5:03 PM

[27V07-pm18S] New antimalarial drug development research - Evalution of antimalarial activity for N-89-ointment-

○Kanako Iguro¹, Rena Isogawa², Nanako Ikeda², Yuji Kurosaki³, Kyung-Soo Chang⁴, Kim Hye-Sook^1,2 (1. Div. Int. Infect. Disease Cont., Grad. Sch. Med. Dent. Pharm. Sci., Okayama Univ., 2. Div. Int. Infect. Disease Cont., Fac. Pharm. Sci., Okayama Univ., 3. Depart. Pharm. Form. Des., Grad. Sch. Medicine Dentistry and Pharmaceutical Sciences, Okayama Univ., 4. Depart. Clinic. Lab. Sci., Coll. Health Sci., Catholic Univ. Pusan, Busan, Korea)

Session information